2020 annual financial data
Karyopharm Therapeutics 2020 Operating margin
Karyopharm Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -159%.
Operating income was -171,850,000 USD and net income was -196,273,000 USD.
Operating cash flow was -160,234,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 108,085,000 USD
- Operating income
- -171,850,000 USD
- Net income
- -196,273,000 USD
- Operating cash flow
- -160,234,000 USD